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Abstract
We present a new analysis of relationships between disease incidence and the preva-
lence of an experimentally defined state of ‘recent infection’. This leads to a clean
separation between biological parameters (properties of disease progression as reflected
in a test for recent infection), which need to be calibrated, and epidemiological state
variables, which are estimated in a cross-sectional survey. The framework takes into
account the possibility that details of the assay and host/pathogen chemistry leave
a (knowable) fraction of the population in the recent category for all times. This
systematically addresses an issue which is the source of some controversy about the
appropriate use of the BED assay for defining recent HIV infection. Analysis of relative
contributions of error arising variously from statistical considerations and simplifica-
tions of general expressions indicate that statistical error dominates heavily over all
sources of bias for realistic epidemiological and biological scenarios. Numerical calcu-
lations validate the approximations made in analytical relations.
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1 Introduction
Reliable estimation of disease incidence (rate of occurrence of new infections) and
prevalence (the fraction of a population in an inflected state) are central to the deter-
mination of epidemiological trends, especially for the allocation of resources and evalu-
ation of interventions. Prevalence estimation is relatively straightforward, for example
by cross-sectional survey. Incidence estimates are notoriously problematic, though po-
tentially of crucial importance. An approximate measure of incidence in a population
is required for the proper planning of sample sizes and costing for clinical trials and
other population based studies. Repeated follow-up of a representative cohort is often
touted as the ‘gold standard’ for estimating incidence, but is costly, time intensive and
still prone to some intrinsic problems. For example, there may be bias in the factors
determining which subjects are lost to follow-up. Furthermore, ethical considerations
demand that a cohort study involve substantial support for subjects to avoid becoming
infected, which may make the cohort unrepresentative of the population of interest.
Numerous methods have been proposed for inferring incidence from single or multi-
ple cross-sectional surveys rather than following up a cohort [1, 2, 3, 4, 5, 6, 7, 8, 9, 10].
A central idea in most of these [1, 3, 4, 5, 6, 8, 10] is to count the prevalence of a state
of ‘recent infection’, which naturally depends on the recent incidence. The relationship
between the two is in general not simple and depends in detail on the recent population
dynamics as well as distributions which capture the inter-subject variability of progres-
sion through stages of infection, as they are observed by the specific laboratory assays
used in the test for recent infection (TRI). For this approach to be sensible, a working
definition of ‘recent infection’ must be calibrated, for example by repeatedly following
up subjects over a period during which they become infected. This is effectively as
much effort as one measurement of incidence by follow-up. The calibration is then used
to infer incidence from each of many subsequent independent cross-sectional surveys.
Owing to the devastating impact of the HIV epidemic, and the many challenges
of research and intervention design, the problem of estimating HIV incidence has at-
tracted considerable interest in recent years. The prospect of using a TRI is in principle
very attractive. Given the range of values of incidence likely to be observed in pop-
ulations with a major epidemic (say 1-10% per annum) a mean definition of ‘recent’
of approximately half a year is desirable to yield reasonable statistical confidence for
sample sizes of a few thousand. The BED assay is currently the leading candidate for
such a test, but controversy has arisen about the possibility of conducting a reliable
calibration. This stems from the fact that a subset of individuals (approximately 5%
[8, 10], potentially variable between viral and host populations) fail to progress above
any statistically useful threshold set on the assay in the definition of ‘recent’ infection.
This subset of individuals, who consequently remain classified as ‘recently infected’ for
all times, poses a problem to which there is currently no consensus remedy.
We present a new analysis of the interaction between epidemiological trends and a
model of inter-subject variability of progression through an experimental category of
‘recent infection’. Our model yields simple formulae for inference even when a fraction
of the population fails to progress out of the recent category. The only physiological
assumption required to deal with the non-progressors is that their survival after infec-
tion is the same as the progressors. This assumption is also implicit in previous work
on using the BED assay to estimate incidence.
A key conceptual point about our analysis, which distinguishes it from all oth-
ers of which we are aware, is that we confront the fundamental limitation of what
can be inferred from a cross-sectional survey. In particular, even perfect knowledge
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of an instantaneous population state does not uniquely determine the instantaneous
incidence. At best, a weighted average of recent incidence can be inferred. Although
the discrepancies between this weighted average and instantaneous incidence can be
shown to be small compared to statistical errors (for our application), it can in principle
be systematically incorporated into estimation of trends from multiple cross-sectional
surveys.
The article is organized as follows. In Section 2 we first develop a basic continuous
time model defined by a time dependent incidence and susceptible population, a distri-
bution of times after infection spent under the threshold on a TRI and a distribution of
post-infection survival times. We note that there is in principle no specific relationship
between the instantaneous incidence and the prevalence of individuals who are infected
and under the threshold. At best, one obtains a relationship between the prevalence
of under-threshold individuals and a convolution of the recent incidence with a specific
weighting function which is implied by the use of a TRI. This relationship in principle
includes all moments of the distribution of the waiting times that individuals spend
under the threshold. We show that, for realistic rates of variation in the susceptible
population, only the mean of the waiting time distribution is needed, and a simple
expression for a weighted average of the incidence is obtained. The basic model is
extended to allow some fraction of individuals (specified by a new parameter) to be
assigned infinite waiting times under the threshold of the TRI. This leads to only
very minor modifications of the previous expression for weighted incidence, namely a
systematic ‘subtraction’ of over-counted ‘not recently infected’ individuals which are
included in the experimental category ‘under threshold’. This subtraction is similar,
but not identical, to that proposed in [10].
Section 3 explores the consequences of designing a cross-sectional survey with a
sample size N based on the relations derived in Section 2. Using a systematic expan-
sion of the incidence estimator in powers of 1/
√
N (derived in the Appendix), we note
consistency of the estimator (no bias in the limit of large N) and derive an approximate
expression for its relative variance. These expressions facilitate error estimation both
from a study design and data analysis point of view. On calibration, we note that
trends, as opposed to absolute values, for incidence can be obtained without any in-
formation about the distribution of finite waiting times under the threshold. However,
an estimate of the fraction of non-progressors is essential. A key observation is that,
for realistic population dynamics and sample sizes, statistical error is much larger than
bias.
Numerical simulations are presented in Section 4. These demonstrate that the
approximate statistical analysis of Section 2 is essentially correct, with discrepancies
of the size expected from the 1/
√
N expansion.
In the conclusion, we note that the framework presented here is quite general and
is applicable to any TRI, as long as any finite probability for non-progression can
be calibrated, survival is the same for progressors and non-progressors, and there is
no ‘relapse’ from over to under the recency threshold. It may be possible to modify
the analysis to relax these requirements. We point out that the relationship between
the present analysis and other proposals for using the BED TRI for measuring HIV
incidence should be more systematically investigated. Some preliminary work in this
direction has already been produced [11].
2 Relating the Prevalence of ‘Recent Infection’
to Incidence
We now outline a quite general approach to relating the key demographic, epidemio-
logical and biological processes which are relevant to the estimation of incidence from
cross-sectional surveys of the prevalence of ‘recent infection’. This refines the naive in-
tuition that a high prevalence of ‘recently infected’ individuals means a high incidence.
The Basic Model
A test for recent infection, such as the CDC STARHS algorithm, is typically obtained
through the administration of two assays of different sensitivity. The more sensitive
test distinguishes infected from healthy individuals and the less sensitive test, applied
to the infected individuals, distinguishes ‘recent’ from ‘long’ established infection.
Consider an assay which yields a quantitative result, the value of which typically
increases with time from infection. The BED assay is of this type. The quantitative
result is a normalized optical density (ODn), which is an increasing function of the
proportion of HIV-1 specific IgG. The hypothetical ongoing observation of an individual
might lead to a curve similar to that displayed in Figure 1A. Such an assay becomes the
less sensitive component of a test for recent infection when we declare a threshold value
and define ‘observed to be recently infected’ to be a test value under the threshold.
In practice, there is inevitably inter-individual variation in these progression curves.
Plotting the curves for multiple individuals on a single graph would lead to something
like Figure 1B. Clearly, the category ‘observed to be recently infected’ is not sharply
defined by a time boundary, and we now adopt the more precise labels under threshold
(U) and over threshold (O). The variability of times spent in the under-threshold
category, conditional on being alive long enough to reach the threshold, is captured
by a distribution of waiting times fU|A which may look something like that shown in
Figure 1C.
It is now possible to construct the basic epidemiological model shown in Figure 2A.
Since our analysis will focus on a variety of survival functions S(t), we shall refer to
the susceptible population as the healthy population H(t). Upon infection, individuals
move from the healthy population to the under-threshold infected population U(t).
Those that live long enough, reach the threshold after a waiting time distributed ac-
cording to fU|A, and enter the over-threshold population O(t). We denote by τU|A a
waiting time generated by the density fU|A. The corresponding cumulative probability
function is given by
FU|A(t) =
∫
t
0
fU|A(s) ds, (1)
while the probability of ‘survival’ (persistence) in the population U, conditional on
being alive, is
SU|A(t) = P(τU|A > t) = 1− FU|A(t), (2)
and the mean waiting time is
E [τU|A] =
∫ ∞
0
τfU|A(τ) dτ =
∫ ∞
0
SU|A(t) dt. (3)
Analogously, we define fA, τA, FA, SA and E [τA] in order to capture survival times
(how long individuals remain alive after the moment of infection). We assume that
survival time and waiting time to threshold are independent in this model. Hence, the
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probability, at a time delay ∆t after infection, of being simultaneously alive and under
the threshold on the assay is
P(τA > ∆t AND τU|A > ∆t) = SU(∆t) = SA(∆t)SU|A(∆t). (4)
Similarly, the probability of being simultaneously alive and over the threshold is
P(τA > ∆t AND τU|A ≤ ∆t) = SA(∆t)(1 − SU|A(∆t)). (5)
Hence, the mean time spent in the category U, accounting for both progression and
mortality, is E [τU].
New infections are generated by a non-homogeneous Poisson process with an inten-
sity (probability per unit time of new arrivals) λ(t). Let the instantaneous incidence
be given by I(t). Then, in a period dt around time t, the expected number of new
cases dC is given by
dC = λ(t) dt = I(t)H(t) dt. (6)
We can now write down numerous expressions resulting from the model. For example,
the expected number of historically accumulated cases up until time t is given by
C(t) =
∫
t
−∞
λ(s) ds =
∫
t
−∞
I(s)H(s) ds. (7)
The expected populations of infected persons under and over the threshold at time t
are
U(t) =
∫
t
−∞
I(s)H(s)P(τA > t− s AND τU|A > t− s) ds
=
∫
t
−∞
I(s)H(s)SU(t− s) ds (8)
and
O(t) =
∫
t
−∞
I(s)H(s)P(τA > t− s AND τU|A ≤ t− s) ds
=
∫
t
−∞
I(s)H(s)SA(t− s)(1− SU|A(t− s)) ds. (9)
Our goal is to relate I for recent times to instantaneous values of H, U and O. We
wish to emphasize the cautionary note that there is fundamentally a loss of information
when one tries to characterize the history of a population based on observations made at
a single time point. The recent historical course of a population, and even instantaneous
values of state variables which are rates, like incidence, are in general not inferable
from counting data obtained in a single survey. This is due to the fact that counts
are, unavoidably, convolutions of historical epidemiological variables, as in (8) and
(9) above. Any attempt to derive incidence estimates from the counting of infections
accumulated in the recent past faces this problem, and at best some sort of weighted
average of the recent values of incidence can be inferred without additional assumptions.
In general, a well defined construction of an estimate for incidence, based on data
obtained in a survey conducted at time t, will be some sort of weighted average of past
values
IW(t) =
∫
t
−∞ I(s)W (s, t) ds∫
t
−∞W (s, t) ds
, (10)
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where W (s, t) is a statistical weight arising from a convolution of population history
and biology. Since our goal is to estimate incidence from a count of recently infected
individuals, a natural weighting function is one that reflects the relative contributions
to this count made by infections from different times in the recent past. Hence, we
consider
W (s, t) = H(s)SU(t− s) (11)
since W (s, t) is proportional to the probability that individuals are
1. available for being infected at time s < t, and
2. still alive and classified as under the threshold at time t, if infected at time s.
Using (11) as the weighting function leads to an expression for the incidence given by
IW(t) =
∫
t
−∞ I(s)H(s)SU(t− s) ds∫
t
−∞H(s)SU(t− s) ds
=
U(t)∫
t
−∞H(s)SU(t− s) ds
. (12)
The numerator in this expression is an instantaneous state variable, while the denom-
inator in principle involves data from the entire history of the system as well as full
knowledge of the survival function SU.
We will shortly show how to obtain a systematic approximation of the denominator,
but a few remarks are in order about the practical meaning of this weighted average.
In the case of constant incidence, the weighted average is the instantaneous value. In
the case of a narrowly peaked distribution fU|A, a constant rate of change of I and
a constant healthy population, the weighted average is approximately equal to the
instantaneous incidence at a time E [τU] /2 prior to the cross-sectional survey. If trends
are fitted to the results of multiple cross-sectional surveys, this time lag could be more
systematically accounted for.
A Simple Expression for Incidence
A simplified expression for weighted incidence in terms of sample and calibration data
is now derived. We express the healthy population using the expansion
H(t+ s) = H(t) +H1s+H2s
2 + . . . (13)
and use the identity ∫ 0
−∞
snSU(−s) ds = (−1)
n
n+1 E
[
τn+1
U
]
, (14)
which follows directly from integration by parts. It then follows that the weighted
incidence (12) can be expressed as
IW(t) =
U(t)∫
t
−∞H(s)SU(t− s) ds
(15)
=
U(t)∫ 0
−∞H(t+ s)SU(−s) ds
=
U(t)
H(t)E [τU]− H12 E [τ2U] + . . .
.
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If the healthy population is approximately constant for the times where the weight
W is non-vanishing, we obtain the simple relation
IW =
U(t)
H(t)E [τU]
, (16)
which gives a weighted recent incidence in terms of instantaneous state variables (H
and U) and the expected waiting time in the under-threshold category.
Expectation values of the form E [τn
U
] are not state variables and should in principle
be measured independently of a particular cross-sectional survey. Usually this would
be accomplished in a calibration cohort follow-up study. Thus, after calibrating some
of these expectation values, we can deal with a truncated expansion for H without
further assumptions about the behavior of I.
Some cautionary comments on calibration are, however, necessary. It seems unlikely
that accurate measurements for terms of higher order than just E [τU] are practically
possible for the case of the BED assay. Finding the non-leading terms Hi (for i ≥ 1)
in the expansion of H will also require considerable demographic research.
These considerations mean that it is most likely that we will be constrained to
use the simple expression (16) even if the healthy population is not approximately
constant over the times where W is non-vanishing. The key question then is: how
severe is the bias introduced by using the simple formula under realistic non-constancy
of the healthy population?
In order to explore this issue systematically we consider a non-constant healthy
population given by H(t) = H0e
αt. This has a conveniently tunable degree of failure
to conform with the constancy assumption required for (16). When α = 0 we have a
constant number of healthy individuals, while a value of α = ln(x) means the popula-
tion grows by a factor of x in one year. We can provide a survival function SU(t) for
time measured in years, roughly inspired by the ODn progression on the BED assay,
by specifying fU to be a Weibull distribution with scale parameter l = 0.57 and shape
parameter k = 8. We now numerically evaluate the denominator of (15) and compare
it to the denominator of the simple formula (16). Note that this bias calculation is
independent of the actual time dependance in I.
In Figure 3, the bias in the naive denominator (reported as a fraction of the unbiased
denominator) is shown as a function of α, reported as the annual percentage growth.
Note that for a population growing at 4% per year, the bias is about 1.1%. As we shall
see later when analyzing a slightly more complex model of a TRI, this is small compared
with the statistical error that arises as a result of using realistic sample sizes. Thus,
bias arising from the non-constancy of the healthy population is not a key concern
unless there is very dramatic variation in H. The bias calculation demonstrated here
is also applicable to the more complex model that now follows.
Modeling Non-progressing Individuals
A complicating factor for the BED assay is the fact that a small number of individuals
utterly fail to progress beyond any practical ODn threshold used to define recency.
This is due to individual variation in biochemical details such as immune response,
for example. The non-progression phenomenon leads to a long term accumulation of
apparently recently infected individuals, as classified by the TRI, even though many
of them have been infected for a long time. There is currently no consensus on how
to handle this complication. We now generalize the previous analysis to the situation
where some individuals fail to progress to the over-threshold category.
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Consider the simple model captured in Figure 2B. At the moment of infection,
individuals transition from the healthy population to either a non-progressing popu-
lation (NP) or to a progressing under-threshold population (PU). The probability of
non-progression is PNP, and hence the probability of progression is 1 − PNP. Those
individuals in PU wait for a stochastic delay after which they move into the progress-
ing over-threshold category PO. In the previous model, fU|A was the distribution of
waiting times governing the transition, but since the waiting times for non-progressing
individuals are infinite, fU|A cannot be normalized. Therefore, in order to specify the
transition times from PU to PO in terms of a normalized density, we introduce the
density of waiting times in the state of being a progressor and under the threshold,
conditional on being a alive, denoted by fPU|A. Then SU|A(t), SPU|A(t) and PNP are
related by
SU|A(t) = (1− PNP)SPU|A(t) + PNP. (17)
The difficulty is that the TRI will classify as ‘recently infected’ all the individuals
in the NP and PU categories even though some potentially large number in NP are
long infected. This can systematically be addressed by the following two key steps.
Firstly, we assume that the same survival function SA is applicable to both progress-
ing and non-progressing individuals. This is true if the differences between individuals
which account for progression versus non-progression do not translate into significant
differences in post-infection survival. This assumption has also been made, at least
implicitly, in previous work on use of the BED assay for estimating HIV incidence (for
example, see [11] for analysis of [8]). Its applicability should in principle be tested, but
we are unaware of any evidence suggesting that it is false.
Secondly, we introduce two artificial categories by separating the non-progressing
population into ‘recently infected’ (NPR) and ‘long infected’ (NPL) sub-populations.
Individuals entering the NPR sub-population are assigned a waiting time drawn from
fPU|A after which they transition to the NPL category. Note that this is a book-keeping
device used for convenience and, unlike the assumption about survival, does not rely on
any property of disease progression. It is now possible to provide a sensible definition
for the class of ‘recently infected individuals’ (R) which has a population given by
R(t) = PU(t) + NPR(t). (18)
Note that, since both PU and NPR now have the same exit waiting times, the distri-
bution of waiting times for R is given by fR|A = fPU|A, with corresponding survival
function SR|A.
These two steps lead to the model in Figure 2C. It is now possible to recycle our
preceding analysis and write down expected counts in these new classes. Survival
in the state of being simultaneously alive and recently infected, is given by SR(t) =
SA(t)SR|A(t), and hence for the progressing populations we obtain
PU(t) = (1− PNP)
∫
t
−∞
I(s)H(s)SR(t− s) ds (19)
and
PO(t) = (1− PNP)
∫
t
−∞
I(s)H(s)SA(t− s)(1− SR|A(t− s)) ds. (20)
Note the similarity with expressions for U(t) and O(t) in the basic model. For the
non-progressing populations we obtain
NPR(t) = PNP
∫
t
−∞
I(s)H(s)SR(t− s) ds (21)
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and
NPL(t) = PNP
∫
t
−∞
I(s)H(s)SA(t− s)(1− SR|A(t− s)) ds. (22)
For convenience we define
ǫ =
PNP
1− PNP
, (23)
and note that
NPR(t) = ǫPU(t) (24)
and, more importantly,
NPL(t) = ǫPO(t). (25)
These equations express the symmetry between the progressing and non-progressing
sub-populations of Figure 2C. Substituting (19) and (21) into (18), we can write
R(t) =
∫
t
−∞
I(s)H(s)SR(t− s) ds. (26)
It is appropriate to use a weighting scheme analogous to the one used in the basic
model
W (s, t) = H(s)SR(t− s), (27)
since W (s, t) is now proportional to the probability that individuals are alive and
classified as recently infected at time t if they become infected at time s, regardless of
whether they are progressors or non-progressors. Then the weighted incidence, denoted
IW, is given by
IW(t) =
∫
t
−∞ I(s)H(s)SR(t− s) ds∫
t
−∞H(s)SR(t− s) ds
=
R(t)∫
t
−∞H(s)SR(t− s) ds
. (28)
The populations of under -threshold (U) and over -threshold (O) individuals are related
to the populations defined in Figure 2C by
U(t) = PU(t) + NPR(t) + NPL(t) (29)
and
O(t) = PO(t). (30)
Using the above two equations and (18) and (25) this means that the population of
recent infections is related to the under-threshold and over-threshold populations by
R(t) = U(t)− ǫO(t). (31)
Performing the same expansion technique as before and assuming a slowly varying
healthy population gives the simple expression
IW(t) =
U(t)− ǫO(t)
H(t)E [τR]
. (32)
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This expresses the incidence in terms of the calibration parameters E [τR] and ǫ (equiv-
alently PNP), and the state variables H, U and O.
All that has changed, as a result of allowing non-progressors into the model, is
the shift in the numerator from U to R = U − ǫO. The same bias calculations as
before apply immediately, but there is an increase in statistical sensitivity. This can
be understood by noting that the gross error in U becomes the dominant part of a
fractional error in R and that R is smaller than U .
3 Statistics and Calibration
The population models of the preceding section are expected to be in ever closer corre-
spondence to a real population as the population size increases. To model the sampling
process of a cross-sectional survey with a sample size N , we rescale the sub-populations
of the continuous time model, at any time t, by the total population size T = H+U+O,
to obtain the population proportions PH = H/T , PU = U/T and PO = O/T . The re-
sult of a survey employing the TRI is the set of three counts NH + NU + NO = N .
These counts are trinomially distributed around their means N¯H = PHN , N¯U = PUN
and N¯O = PON . These observed counts turn equation (32) into an estimator for the
recently weighted incidence Iest given by
Iest =
1
E [τR]
NU − ǫNO
NH
. (33)
It should be noted that we do not address issues relating to experiment design and
selection bias.
Statistical Fluctuations
As noted in the preceding section, in a relatively established epidemic where the small-
est class is U, the major source of fluctuations in Iest is NU. Crudely speaking then, we
can estimate the reproducibility by blaming all the statistical uncertainty on the mea-
surement of NU, which has a standard deviation σ(NU) =
√
NPU(1− PU) ≈
√
NPU.
This leads to the ‘back of the envelope’ formula for the relative standard deviation
given by
σ(Iest)
Iest
≈ 1
PU − ǫPO
√
PU
N
. (34)
However, the trinomial counts in the estimator (33) fluctuate and are correlated since
they are constrained to add up to the sample size N . In the Appendix we demonstrate
how these counts can be modeled by two independent draws (α1 and α2) from a stan-
dard normal distribution. We obtain a particular incidence estimator by inserting the
counts, as functions of α1 and α2 into (33). Organizing the resulting expression into a
natural expansion in powers of 1/
√
N gives
Iest(α1, α2) = Iest(0, 0)−
1√
N
[
α1
γ1(PU − ǫPO)
P2
H
(PO + PU)
+ α2
γ2(1 + ǫ)
PH
]
1
E [τR]
+O
(
1
N
)
, (35)
where
γ1 =
√
PH(1− PH) and γ2 =
√
POPU
PO + PU
(36)
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The leading term,
Iest(0, 0) =
1
E [τR]
N¯U − ǫN¯O
N¯H
=
1
E [τR]
PU − ǫPO
PH
, (37)
is just the estimator evaluated at the expectation values of the counts. The O(1/N)
term, which we have omitted, contains a term proportional to α21. This means that
there is in principle a finite sample size bias in the estimator, which is however sup-
pressed by O(1/N) relative to the dominant term, as is borne out by numerical calcu-
lations in Section 4. The retained sub-leading term (of order O(1/
√
N)) is distributed
according to a bivariate normal distribution. Thus, to this order, there is no bias and
we can read off the likelihood of observing a value of Iest,
L(Iest) = f
(
Iest − Iest(0, 0)
σ(Iest)
)
, (38)
where f(·) is the standard normal density and
σ(Iest)
Iest(0, 0)
=
√
1
N
1
PO + PU
(
1
PH
+
POPU(1 + ǫ)2
(PU − ǫPO)2
)
. (39)
Comparison with numerical simulation suggests that this approximate result is
essentially indistinguishable from the exact answer in the regime of realistic values for
N and the proportions (PH, PU and PO), given that in practice one uses the sample
proportions as estimates of the population proportions. Figure 4 plots the relations
(34) and (39) for different values of PNP and fixed values of PH, PO and PU. Comparison
with Figure 3 confirms that the truncation of the expansion of the healthy population
to a constant term (the crucial step in obtaining the simple incidence relation on which
the estimator is based) leads to a bias that is small compared to realistic statistical
errors. The close correspondence between the two curves suggests that the simple
formula (34) should be sufficiently accurate to choose a sample size for an intended
study.
Calibration
Aside from the sample counts NH, NU and NO, all other quantities in relations of
the kind derived in the previous section, such as E [τR] in the estimator, should be
regarded as parameters that need to be estimated independently of a cross-sectional
survey used to infer incidence. Even in the more general case, where the healthy
population is allowed to vary considerably over the time when the weighting function
is non-vanishing, calibration consists only of estimating PNP and expressions of the
form E [τn
R
]. We have already remarked that for the BED assay it will probably not be
possible to obtain reasonable estimates of E [τn
R
] for values of n other than 1 and that
it appears that only this term is really needed for practical purposes.
Note that if one wishes merely to estimate trends in incidence, as opposed to abso-
lute incidence values, then it is not necessary to have an estimate for E [τR] at all, since
it is just an overall factor. If the overall scale of incidence estimates is to be known,
considerable effort will need to be invested in the estimation of E [τR]. Note that this
is the mean time progressing individuals spend under the threshold, with mortality
accounted for.
However, surveys conducted at different times will not yield comparable values of
Iest ∝ (U − ǫO)/H unless ǫ (equivalently PNP) is known with some accuracy, since it
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appears in one of two terms in the numerator. Consider two surveys which use the
same point estimate
ǫ = ǫ0 + ǫ1, (40)
where ǫ0 is the real value and ǫ1 is the error due to methodological and statistical
factors. The first survey obtains values of N
(1)
H , N
(1)
U and N
(1)
O and the second obtains
values of N
(2)
H , N
(2)
U and N
(2)
O . This leads to an estimate of the difference between the
two incidences of
∆Iest(ǫ) = I
(1)
est (ǫ)− I(2)est (ǫ) = N
(1)
U − ǫN (1)O
N
(1)
H E [τR]
− N
(2)
U − ǫN (2)O
N
(2)
H E [τR]
. (41)
Knowledge of the exact value ǫ0 leads to
∆Iest(ǫ0) = I
(1)
est (ǫ0)− I(2)est (ǫ0) =
N
(1)
U − ǫ0N (1)O
N
(1)
H E [τR]
− N
(2)
U − ǫ0N (2)O
N
(2)
H E [τR]
, (42)
from which we see that the error in ∆Iest, due to the error in ǫ, is
∆Iest(ǫ)−∆Iest(ǫ0) = ǫ1
E [τR]
(
N
(2)
O
N
(2)
H
− N
(1)
O
N
(1)
H
)
. (43)
The direction and magnitude of error depend in detail on many factors, such as pop-
ulation renewal and long term post-infection survival. While it is not possible to
summarize all the effects that may be produced by imperfect estimation of PNP, in
Section 4 we conduct a number of numerical simulations which demonstrate the kind
of bias that may arise.
4 Numerical Simulations
In this section we briefly outline two numerical simulations. The first serves to test
the accuracy of the bias and standard deviation estimates derived from the trunca-
tion of the systematic expansion of the stochastic estimator Iest(α1, α2). For each of
10,000,000 iterations, two standard normal variables were drawn. Counts for healthy,
under-threshold and over-threshold sub-populations, within a sample of size N = 5000,
were generated according to the procedure provided in the Appendix. This algorithm
incorporates the assumption that the trinomial distribution of the sample proportions
can be approximated as normal, but involves no truncation of the estimator in powers
of 1/
√
N . The resulting ensemble of point estimates Iest produced suitably converged
estimates for the mean and standard deviation.
The entire procedure of the preceding paragraph was repeated for values of PO ∈
[0.1, 0.5]. For each value of PO, the value of PU was varied to produce an incidence in
the range [0.01, 0.2]. The average fractional discrepancy between the mean incidence
and Iest(0, 0) was 0.0003, with values ranging from 0.00001 to 0.0008, confirming that
the intrinsic sampling bias is of order 1/N . The average fractional discrepancy between
the observed standard deviation of the incidence and the approximate expression (39)
was 0.0006, with values ranging from 0.00004 to 0.001, which is also consistent with
the truncation at O(1/
√
N).
A second simulation demonstrates the use of the simple expression (33) for in-
cidence estimation. Arrival times of new infections were generated according to a
non-homogeneous Poisson process with intensity given by λ(t) = H(t)I(t) as described
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in more detail below. Newly infected individuals were initially classified as under the
recency threshold of a TRI. A fraction 1 − PNP progressed to the over-threshold cat-
egory according to waiting times generated by fR|A. Weibull functions were used for
the waiting time distributions fR|A and fA. Unique individuals were drawn from the
population at intervals, to produce counts NH, NU and NO, and hence estimates for
incidence.
To demonstrate the incidence estimation process, a 50 year population scenario
was produced. Figure 5 shows the Weibull distributions used for fA and fR|A (top) and
the corresponding survival curves SA and SR|A (bottom). The Weibull shape and scale
parameters for the distributions were chosen to give approximately realistic values for
the mean and standard deviations for the window period and infected life expectancy,
as detailed in Table 1. The healthy population was set to H(t) = 100, 000 + 5, 000t,
with t measured in years. The incidence was set at 0.01 (hazard per person per year)
for the first ten years, climbing linearly to 0.1 over the next ten years, then remaining
at this high level for a further ten years, followed by ten years of linear decline to 0.03
and maintained at this level for the last ten years of the simulation.
Shape (k) Scale (l) Mean Standard Dev.
Life expectancy (fA) 4.5 8.83 8 years 2 years
Window period (fR|A) 8 0.58 200 days 30 days
Table 1: Weibull parameters for the Monte Carlo simulation (survival
time measured in years).
Figure 6 shows output from this simulation. The input incidence parameter is indi-
cated as the dotted instantaneous incidence curve. A sample of 5, 000 individuals was
surveyed every year, and an incidence estimate was produced using the simple estima-
tor (33) with exact values of E [τR] and PNP, i.e., assuming perfect calibration. These
point estimates are indicated as estimated incidence values, using ‘+’ symbols. The
combined effects of the previously noted time convolution, in IW, as well as stochastic
departure from means in the simulated population, make the input incidence parameter
an unrealistic target for simulated incidence measurements. Thus, the solid weighted
incidence line has been displayed, which uses full knowledge of all population members’
classification into H, U or O, inserted into (28) with full knowledge of the denomina-
tor, (both the non-constant H(t) and the exact SR). This is essentially all that the
incidence estimation algorithm can be asked to reproduce. A two standard deviation
envelope around the weighted incidence line, calculated from (39) using knowledge of
the full population, is shown as two dashed lines.
In Section 3 it was shown that incidence trends can be extracted without E [τR]
calibration, while an estimate for PNP is vital. We now explore the extent to which the
accuracy of the estimate of PNP affects the ability to determine a trend in incidence.
Population fractions for H, U and O were extracted at six times from the population
simulation described above and are shown in Table 2. Four instances of incidence trend
estimation were simulated by selecting the time intervals (15, 20), (20, 30), (30, 35) and
(40, 50). We considered the trends that would be observed if incidence were measured
at the beginning and end of each of these intervals using (37). In order to focus on
the bias introduced by imperfect estimation of PNP, rather than sample size effects, we
assumed perfect knowledge of PH, PU and PO. For each of these intervals, we calculated
an incidence estimate at the beginning and end, as a function of the estimated value of
PNP (the true value being 0.05), assuming E [τR] is known exactly. We also calculated
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the estimated fractional change in incidence over each interval. Note that the fractional
change does not depend on E [τR]. The results are shown in Figure 7, where the four
intervals (15, 20), (20, 30), (30, 35) and (40, 50) are referred to as scenarios A, B, C and
D, respectively.
In each case, the effect of the error in the estimation of PNP is quite different, as
can be understood by considering how (43) is impacted by the system history. Note
that case B and case D both simulate intervals over which incidence is approximately
constant, but the impact (on the estimated incidence change) of incorrect estimation
of PNP does not even agree in sign. At a time of 40 years, the incidence estimate
becomes negative when the PNP estimate is higher than 0.0882. This breakdown of the
model results in the divergence of the fractional change in estimated incidence over the
interval in scenario D. In short, incorrect estimates of PNP can lead to the fundamental
breakdown of the inference scheme. This makes sense, as PNP impacts the long term
accumulation of individuals in the PO category.
Time (years)
15 20 30 35 40 50
PH 0.849 0.687 0.576 0.602 0.694 0.814
PU 0.030 0.050 0.051 0.041 0.027 0.022
PO 0.121 0.263 0.373 0.357 0.279 0.164
Table 2: Population fractions in H, U and O within a 50 year epidemic
scenario.
5 Discussion and Conclusion
We have presented a detailed analysis of relations between recent incidence in a pop-
ulation and counts of ‘recently infected’ individuals. These are in principle complex
convolutions involving the epidemiological history as well as all information about the
distribution of waiting times in the recently infected category. When the healthy pop-
ulation undergoes realistically modest variation on the time scale of the definition of
recency implied by the TRI, we obtain simplified forms which incur very little er-
ror. The simplified relations form the basis of estimators which are shown to have
considerably more variance than bias under realistic demographic and epidemiological
assumptions.
Noting that the assumptions of our model are the least restrictive of any BED
based HIV incidence estimation method of which we are aware, we now consider its
limitations. We have only modeled one direction of progression of individuals from
an experimentally defined state of ‘recent’ infection to ‘non-recent’ infection. The re-
verse apparently occurs for BED optical density in some terminal stage AIDS patients.
This process constitutes a substantial complication, and further work is required to
investigate how it may be incorporated into an analytical model of the kind developed
here. It may be worth exploring previous suggestions [8] to use additional information,
from questionnaires or other assays, to remove end-stage patients from the observed
recent count. We have also not considered the possibility that calibration parameters
are functions of time, for example as a result of substantial vaccine uptake in a pop-
ulation. Even more subtle is a point raised under calibration, namely that imperfect
estimation of the non-progressing fraction of the population leads to a complex bias in
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incidence estimates. This bias is dependent on factors not even present in the incidence
estimator, such as long term survival post infection.
A key observation is that, for the purposes of estimating incidence from a TRI,
there is no fundamental obstacle posed by having a known fraction of individuals
fail to progress over the recency threshold, as long as their distribution of survival
times from infection is the same as in the progressing population. In fact, an accurate
estimate of this non-progressing fraction alone, is sufficient (and necessary) to infer
trends in incidence. This fraction could possibly be estimated for the BED assay
from historical records, since there are many viable samples in storage with supporting
clinical information indicating long-infected status. However, as demonstrated in the
calculations of Section 4, a suitably large error in the estimate of PNP can render TRI
based incidence estimates meaningless. A calibration of the mean finite waiting time
is required in order to estimate absolute values of incidence. Prospective follow-up is
probably the only practical way to estimate this parameter.
In contrast to our model, which has only two calibration parameters, the model
of McDougal et al. [8] appears to have three (sensitivity, short-term specificity and
long-term specificity). In a separate short note [11] we demonstrate that, under their
own assumptions, these parameters can be reduced to ours. This has two advantages—
our parameters are easier to calibrate and assuming independence of their parameters
would lead to incorrect error estimates.
Besides the explicit assumptions noted, the analysis presented here is quite general.
Tests for recent infection continue to be of interest, and new assays are likely to be
developed both for HIV infection and other important diseases. In summary, we have
presented a simple incidence estimator and a detailed analysis of its likelihood function,
which can inform design of appropriate calibration studies and cross-sectional incidence
estimation surveys, and can also form the basis of systematic inference algorithms for
processing the data obtained from such surveys.
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Appendix
Given a sample of N subjects tested using the TRI, we derive a systematic expansion,
in powers of O(1/
√
N), for the estimator
Iest =
1
E [τR]
NU − ǫNO
NH
=
1
E [τR]
PU − ǫPO
PH
, (44)
where the counts NX = PXN fluctuate trinomially around their means N¯X = PXN , with
standard deviations σX =
√
NPX(1− PX), or, alternatively, the realized sample pro-
portions PX fluctuate multinomially around their means PX, with standard deviations
σPX =
√
PX(1− PX)/N . In order to account for fluctuations in the sample counts, as
well as their correlations, we express the three counts as the result of two independent
random draws. We assume the counts are sufficiently large so that binomial distri-
butions can be approximated by normal distributions—which will be the case if the
survey is to have any reasonable accuracy.
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• Draw a number α1 from a standard normal distribution and set
NH = N¯H + σ1α1, (45)
where
σ1 = σS =
√
NPH(1− PH) =
√
Nγ1. (46)
Defining γ1 allows us to keep track of powers of 1/
√
N .
• Draw a number α2 from a standard normal distribution and set
NU = P
′
U
(N −NH) + σ2α2
= P′
U
N(1− PH)− P′Uσ1α1 + σ2α2
= PUN − P′Uγ1α1
√
N + σ2α2 (47)
and
NO = P
′
O
(N −NH)− σ2α2
= P′
O
N(1− PH)− P′Oσ1α1 − σ2α2
= PON − P′Oγ1α1
√
N − σ2α2 (48)
where
P
′
U
=
PU
PU + PO
and P′
O
= 1− P′
U
(49)
are the probabilities of an individual being in U and O given that they are not in
H, and
σ2 = σB|α1 =
√
(N −NH)P′UP′O =
√
Nγ2
(
1 +O
(
1√
N
))
(50)
is the standard deviation of NU (and NO) subject to α1 having been determined,
so that
γ2 =
√
POPU
PO + PU
. (51)
The sample proportions can now be written as:
PH = PH +
1√
N
α1γ1
PU = PU − 1√
N
(
α1P
′
U
γ1 − α2γ2
)
+O
(
1
N
)
PO = PO − 1√
N
(
α1P
′
O
γ1 + α2γ2
)
+O
(
1
N
)
(52)
Note that this procedure works independently of the order in which the values ofNH, NU
and NO are assigned from the random α’s. We can explicitly insert this decomposition
into the expression for Iest to obtain an expression for the estimator in terms of two
independent draws from a standard normal distribution. Keeping only the O(1) and
O(1/
√
N) terms explicit leads to
Iest(α1, α2) = Iest(0, 0)−
1√
N
[
α1
γ1(PU − ǫPO)
P2
H
(PO + PU)
+ α2
γ2(1 + ǫ)
PH
]
1
E [τR]
+O
(
1
N
)
, (53)
where
Iest(0, 0) =
1
E [τR]
PU − ǫPO
PH
. (54)
Two key observations immediately follow:
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• The proposed Iest is a consistent estimator in the sense that terms with bias are
at least O(1/N) suppressed relative to the dominant term.
• To order O(1/
√
N), Iest is Gaussian with relative variance(
σ(Iest)
Iest(0, 0)
)2
=
1
N
1
PO + PU
(
1
PH
+
POPU(1 + ǫ)
2
(PU − ǫPO)2
)
. (55)
References
[1] R. Brookmeyer and T.C. Quinn. Estimation of current human immunodeficiency
virus incidence rates from a cross-sectional survey using early diagnostic tests.
American Journal of Epidemiology, 141(2):166–172, 1995.
[2] S.J. Posner et al. Estimating HIV incidence and detection rates from surveillance
data. Epidemiology, 15:164–172, 2004.
[3] R.S. Jannssen et al. New testing strategy to detect early HIV-1 infection for use in
incidence estimates and for clinical and prevention purposes. JAMA, 280(1):42–48,
1998.
[4] B.S. Parekh et al. Quantitative detection of increasing HIV type 1 antibodies after
seroconversion: A simple assay for detecting recent hiv infection and estimating
incidence. AIDS Research and Human Retroviruses, 18(4):295–307, 2002.
[5] B.S. Parekh and J.S. McDougal. New approaches for detecting recent HIV-1
infection. AIDS Rev, 3:183–193, 2001.
[6] S.R. Cole, H. Chu, and R. Brookmeyer. Confidence intervals for biomarker-based
human immunodeficiency virus incidence estimates and differences using prevalent
data. American Journal of Epidemiology, 165(1):94–100, 2006.
[7] C.M.R. Nascimento et al. Estimation of HIV incidence among repeat anonymous
testers in Catalonia, Spain. AIDS Research and Human retroviruses, 20(11):1145–
1147, 2004.
[8] J.S. McDougal et al. Comparison of HIV type 1 incidence observed during lon-
gitudinal follow-up with incidence estimated by cross-sectional analysis using the
BED capture enzyme immunoassay. AIDS Research and Human Retroviruses,
22(10):945–952, 2006.
[9] K. Wong, W. Tsai, and L. Kuhn. Estimating HIV hazard rates from cross-sectional
HIV prevalence data. Statistics in Medicine, 25(15):2441–2449, 2006.
[10] J. W. Hargrove et al. Improved HIV-1 incidence estimates using the BED capture
enzyme immunoassay. AIDS, 22(4):511–518, 2008.
[11] T.A. McWalter and A. Welte. On the estimation of the proportion of true
recent infections using the BED capture enzyme immunoassay. Available at
http://arxiv.org/abs/0806.1297, June 2008.
17
0 100 200 300 400 500 600
0
0.5
1
1.5
2
2.5
A) Single Optical Density Curve
Days
N
or
m
al
iz
ed
 O
pt
ica
l D
en
sit
y
0 100 200 300 400 500 600
0
0.5
1
1.5
2
2.5
B) Multiple Optical Density Curves
Days
N
or
m
al
iz
ed
 O
pt
ica
l D
en
sit
y
0 50 100 150 200 250 300 350
0
1
2
3
4
5
6
C) Distribution of Waiting Times Under the Threshold
Days
Figure 1:
A) Hypothetical individual BED normalized optical density (ODn) as a function of
time since infection.
B) Hypothetical collection of individual ODn progression plots with inter-individual
variability and an arbitrary ODn threshold which can be used to define recent
infection.
C) Hypothetical distribution of times spent under the ODn threshold after infection,
which approximately captures the mean and variance of the sample of individual
progression curves in B).
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Figure 2:
A) The basic epidemiological/TRI progression model. Members of the healthy pop-
ulation H are subject to a per unit time hazard (incidence) I of infection. After
infection, individuals enter the under-threshold population U. Here they spend a
time distributed according to fU|A, after which they spend the remainder of their
lifetime, if any, in the over-threshold population O.
B) The basic model modified to accommodate non-progressors on the TRI. Now,
upon infection, a proportion PNP of individuals remain forever under the threshold
of the TRI, i.e., they enter the NP category. The remaining proportion, 1− PNP,
the progressors, are assigned a waiting time from fPU|A, and spend this time
in the ‘progressing, under-threshold’ population PU. Those that survive long
enough spend the remainder of their lifetime in the ‘progressing, over-threshold’
population PO
C) Modified model with separation of non-progressors into ‘recent’ and ‘long’ in-
fected categories. This model contains the same epidemiology and biology as the
model in B), with the introduction of a bookkeeping device which facilitates the
definition of a calibratable category of ‘recently infected’ individuals. The non-
progressors are assigned waiting times drawn from the distribution observed in
the progressing population, and spend this waiting time in the ‘non-progressing
recently infected’ (NPR) category, before moving to the ‘non-progressing long
infected’ (NPL) category.
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Figure 3: Fractional error in the simple incidence relation (16) versus the full relation (15), as
a function of growth rate of the healthy population, quoted as a percentage annual growth.
The scenario is defined by: S(t) = S(0)eαt and fU is a Weibull distribution with scale
parameter l = 0.57 and shape parameter k = 8. The parameter α is varied to produce
deviation from a constant healthy population (α = 0) in which limit equation (16) is exact.
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Figure 4: Plots of the crude formula (34) (dashed line) and the systematic formula (39)
truncated after O(1/
√
N) (solid line) for the standard deviation of incidence estimates,
expressed as a fraction of the leading term Iest(0, 0), and plotted as a function of the non-
progressing fraction PNP, for fixed values PH = 0.60, PU = 0.05 and PO = 0.35.
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Figure 5: Graphical representation of the densities fA and fR|A for survival times and times
under threshold in the progressing population (top) and the corresponding survival proba-
bilities SA and SR|A (bottom). Parameters for these curves are detailed in Table 1.
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Figure 6: Full stochastic simulation of population with epidemic, individual survival times,
and annual sampling of 5, 000 individuals. The healthy population was set to H(t) =
100, 000 + 5, 000t with time measured in years. The instantaneous incidence parameter
is the dotted curve. The target of the estimates is the weighted incidence (solid line), which
was calculated explicitly as per (28) from all the known inputs. This is flanked by a two
standard deviation envelope (dashed lines). Simulated estimated incidence (+ symbols) were
obtained by using sample counts in the simple estimator (33). The calibration parameters
E [τR] and PNP were assumed to be known exactly.
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Figure 7: Absolute incidence estimates and estimated fractional incidence changes for four
pairs of successive times from Table 2.
24
